CNTB (Connect Biopharma Holdings) Change In Receivables : $-0.79 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Connect Biopharma Holdings Change In Receivables?

Connect Biopharma Holdings's change in receivables for the quarter that ended in Dec. 2024 was $2.42 Mil. It means Connect Biopharma Holdings's Accounts Receivable declined by $2.42 Mil from Jun. 2024 to Dec. 2024 .

Connect Biopharma Holdings's change in receivables for the fiscal year that ended in Dec. 2024 was $-0.79 Mil. It means Connect Biopharma Holdings's Accounts Receivable increased by $0.79 Mil from Dec. 2023 to Dec. 2024 .

Connect Biopharma Holdings's Accounts Receivable for the quarter that ended in Dec. 2024 was $0.79 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Connect Biopharma Holdings's Days Sales Outstanding for the six months ended in Dec. 2024 was 75.11.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Connect Biopharma Holdings's liquidation value for the six months ended in Dec. 2024 was $85.18 Mil.

Connect Biopharma Holdings Change In Receivables Historical Data

The historical data trend for Connect Biopharma Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Connect Biopharma Holdings Change In Receivables Chart

Connect Biopharma Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-1.43

-2.31

4.05

-0.79

Connect Biopharma Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Receivables	Get a 7-Day Free Trial						4.28	-0.32	0.32	-3.21	2.42

Connect Biopharma Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.79 Mil.

Connect Biopharma Holdings (NAS:CNTB) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Connect Biopharma Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.789	/	1.917	*	91
=	75.11

2. In Ben Graham's calculation of liquidation value, Connect Biopharma Holdings's accounts receivable are only considered to be worth 75% of book value:

Connect Biopharma Holdings's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	93.708	-	9.118	+	0.75 * 0.789	+	0.5 * 0
=	85.18

Connect Biopharma Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of Connect Biopharma Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Connect Biopharma Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Connect Biopharma Holdings Ltd (NAS:CNTB) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

12265 El Camino Real, Suite 350, San Diego, CA, USA, 92130

Website

https://www.connectbiopharm.com

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.